The makeup industry is trying to convince women that looking good on the outside starts from within - but it's unclear whether the products they're trying to hawk are safe and effective.
Acadia Pharmaceuticals received FDA approval on Friday for its drug, Nuplazid (pimavanserin), the first of its kind to treat psychosis associated with Parkinson’s disease.
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells.
Vernakalant, a new drug for treating recent-onset atrial fibrillation, has proved to be considerably more effective than Ibutilide, an established drug in this indication.
Vice President Joe Biden found common cause with Pope Francis on Friday at the Vatican for a global commitment to fund cancer research.
The FDA first proposed its risk-management plan in 2010, before the CDC had formally identified opioid overdoses as a national epidemic.
The research suggests that Hsp90 inhibitors could be effective in prostate cancers that have become resistant to treatment and started spreading round the body.
Investigators have developed a promising method of identifying new antimicrobials that target these organisms.
Genetic sequencing allows us to determine how an infection travels – even tracing it across continents – with incredible precision.
The first commercial test for the Zika virus has been cleared for emergency use in the U.S. and could be available by next week.
The drug is also currently under regulatory review in the United States, Switzerland, Canada and Australia.
The world's largest maker of diabetes treatments, Novo Nordisk, said on Friday that the US launch of ultra-long acting insulin Tresiba had been "encouraging" as it reported a drop in first quarter profit.
Researchers have discovered a new technique to enhance and maintain brain excitability that could increase sensory and pain threshold, which could be used to alleviate chronic pain in people who cannot take medication.
Bogus medicines promise a lucrative gain for unscrupulous peddlers worldwide. But even if they’re caught, the human health toll has already been taken. A new study proposes to look at the fraudulent phenomenon from a criminology and forensic perspective.
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer's and rheumatoid arthritis - and identifying new drug targets and therapies - thanks to work by three computational biology research teams.